Document is current
Any future updates will be listed below
-
Authors
Bhattacharya, Arkajyoti https://orcid.org/0000-0003-1479-0739
Bense, Rico D.
Urzúa-Traslaviña, Carlos G. https://orcid.org/0000-0003-1146-1630
de Vries, Elisabeth G. E. https://orcid.org/0000-0002-8949-7425
van Vugt, Marcel A. T. M.
Fehrmann, Rudolf S. N. https://orcid.org/0000-0002-7516-315X
- License Information
-
More Information
Article History
Received: 11 June 2019
Accepted: 20 January 2020
First Online: 5 February 2020
Competing interests
: E.G.E.d.V. reports institutional financial support for advisory board/consultancy from Sanofi, Daiichi, Sankyo, NSABP, Pfizer and Merck, and institutional financial support for clinical trials or contracted research from Amgen, Genentech, Roche, AstraZeneca, Synthon, Nordic Nanovector, G1 Therapeutics, Bayer, Chugai Pharma, CytomX Therapeutics and Radius Health, all unrelated to the submitted work. All other authors declare no competing interests.
